Protection of BNT162b2 vaccine booster against Covid-19 in Israel
…, Y Goldberg, M Mandel, O Bodenheimer… - New england journal …, 2021 - Mass Medical Soc
Background On July 30, 2021, the administration of a third (booster) dose of the BNT162b2
messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 …
messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 …
Waning immunity after the BNT162b2 vaccine in Israel
Background In December 2020, Israel began a mass vaccination campaign against coronavirus
disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp …
disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp …
Protection and waning of natural and hybrid immunity to SARS-CoV-2
Background Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
provides natural immunity against reinfection. Recent studies have shown waning of the …
provides natural immunity against reinfection. Recent studies have shown waning of the …
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
…, Y Goldberg, M Mandel, O Bodenheimer… - … England Journal of …, 2022 - Mass Medical Soc
Background On January 2, 2022, Israel began administering a fourth dose of BNT162b2
vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth …
vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth …
Protection against Covid-19 by BNT162b2 booster across age groups
…, Y Goldberg, M Mandel, O Bodenheimer… - … England Journal of …, 2021 - Mass Medical Soc
Background After promising initial results from the administration of a third (booster) dose of
the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to persons 60 years of age or …
the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to persons 60 years of age or …
Protection and waning of natural and hybrid COVID-19 immunity
BACKGROUND Infection with SARS-CoV-2 provides substantial natural immunity against
reinfection. Recent studies have shown strong waning of the immunity provided by the …
reinfection. Recent studies have shown strong waning of the immunity provided by the …
Effects of BNT162b2 Covid-19 vaccine booster in long-term care facilities in Israel
…, B Varticovschi, O Bodenheimer… - … England Journal of …, 2022 - Mass Medical Soc
Covid-19 Booster in Long-Term Care Facilities During a surge in cases of Covid-19 in Israel,
a rapid deployment of BNT162b2 booster injections was initiated in long-term care facilities …
a rapid deployment of BNT162b2 booster injections was initiated in long-term care facilities …
Association of receipt of the fourth BNT162b2 dose with Omicron infection and COVID-19 hospitalizations among residents of long-term care facilities
…, AY Mizrahi, B Boltyansky, O Bodenheimer… - JAMA internal …, 2022 - jamanetwork.com
Importance The administration of a fourth BNT162b2 COVID-19 vaccine dose was approved
in Israel in December 2021 for individuals 60 years or older who were vaccinated with a …
in Israel in December 2021 for individuals 60 years or older who were vaccinated with a …
Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine
Israel began administering a BNT162b2 booster dose to restore protection following the
waning of the 2-dose vaccine. Biological studies have shown that a “fresh” booster dose leads …
waning of the 2-dose vaccine. Biological studies have shown that a “fresh” booster dose leads …
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study
Background The BNT162b2 (Pfizer-BioNTech) two-dose vaccine regiment for children and
the BNT162b2 third dose for adolescents were approved shortly before the SARS-CoV-2 …
the BNT162b2 third dose for adolescents were approved shortly before the SARS-CoV-2 …
